Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Zimmer Holdings
(NY:
ZBH
)
115.85
-3.48 (-2.92%)
Official Closing Price
Updated: 4:10 PM EDT, May 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Zimmer Holdings
< Previous
1
2
3
4
5
6
7
Next >
Benzinga's Top Ratings Upgrades, Downgrades For December 9, 2021
December 09, 2021
Upgrades According to BMO Capital, the prior rating for Nuvei Corp (NASDAQ:
Via
Benzinga
2 Medical Device Stocks Wall Street Predicts Will Rally 35% Or More
December 09, 2021
Boston Scientific Corporation is a developer, manufacturer, and marketer of medical devices used in a range of interventional medical specialties.
Via
Talk Markets
Expert Ratings For Zimmer Biomet Holdings
December 07, 2021
Over the past 3 months, 4 analysts have published their opinion on Zimmer Biomet Holdings (NYSE:
Via
Benzinga
Analyzing Zimmer Biomet Holdings's Unusual Options Activity
August 03, 2021
On Tuesday, shares of Zimmer Biomet Holdings (NYSE:ZBH) saw ...
Via
Benzinga
Recap: Zimmer Biomet Q2 Earnings
August 03, 2021
Shares of Zimmer Biomet Holdings (NYSE:ZBH) remained unaffected after the company reported Q2 results. Quarterly Results Earnings per share rose 3700.00% over the past year...
Via
Benzinga
7 F-Rated Dividend Stocks You Shouldn’t Get Suckered Into
December 08, 2021
As dividend stocks, these companies aren’t worth a second glance, even though some boast tempting dividend yields.
Via
InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For December 7, 2021
December 07, 2021
Upgrades For CarMax Inc (NYSE:
Via
Benzinga
Recap: Zimmer Biomet Q1 Earnings
May 04, 2021
Shares of Zimmer Biomet Holdings (NYSE:ZBH) moved higher by 0.0% in pre-market trading after the company reported Q1 results. Quarterly Results Earnings per share increased...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 23, 2021
November 23, 2021
Upgrades Keefe, Bruyette & Woods upgraded the previous rating for CBRE Group Inc (NYSE:
Via
Benzinga
10 Biggest Price Target Changes For Friday
November 05, 2021
Wedbush raised Uber Technologies, Inc. (NYSE:UBER)...
Via
Benzinga
Zimmer Biomet Holdings Inc (ZBH) Q3 2021 Earnings Call Transcript
November 04, 2021
ZBH earnings call for the period ending September 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Zimmer Biomet Shares Hit After Lowering Annual Guidance
November 04, 2021
Zimmer Biomet Holdings Inc's (NYSE: ZBH) Q3 sales decreased marginally by 0.3% Y/Y to $1.92 billion (down 0.8% on a constant currency basis), missing the...
Via
Benzinga
Price Over Earnings Overview: Zimmer Biomet Holdings
November 02, 2021
Looking into the current session, Zimmer Biomet Holdings Inc. (NYSE:ZBH) is trading at $145.73, after a 0.1% decrease. Over the past month, the stock fell by 0.64%,...
Via
Benzinga
Software Error Prompts Zimmer Biomet To Recall Rosa One Robotic Neurosurgery Platform
November 01, 2021
Zimmer Biomet Holdings Inc (NYSE: ZBH) is facing a Class I recall of its Rosa One Brain platform. Devices ranging from biopsy needles to endoscopes to deep brain...
Via
Benzinga
Topics
Product Recall
Exposures
Legal
Product Safety
The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO
November 04, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck's Oral Antiviral COVID-19 Pill Authorized In UK Merck &...
Via
Benzinga
Exposures
COVID-19
Zimmer Biomet Scores FDA De Novo Nod For Smart Knee Implant
August 30, 2021
Zimmer Biomet Holdings Inc (NYSE: ZBH) and Canary Medical have announced that the FDA granted de novo classification for Persona IQ. The de novo grant...
Via
Benzinga
Exposures
Product Safety
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
October 31, 2021
Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc...
Via
Benzinga
FDA Approves Zimmer Biomet's Rosa Hip Personalized Robotic System
August 18, 2021
Zimmer Biomet Holdings Inc (NYSE: ZBH) has received FDA 510(k) clearance for its Rosa Hip system for robotically-assisted surgery. The system is designed for...
Via
Benzinga
Exposures
Product Safety
Zimmer Biomet Holdings Inc (ZBH) Q2 2021 Earnings Call Transcript
August 03, 2021
ZBH earnings call for the period ending June 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Zimmer Biomet Stock Falls After Lowering Bottom End Of FY21 Outlook; Q2 Earnings Beat
August 03, 2021
Zimmer Biomet Holdings Inc (NYSE: ZBH) posted Q2 adjusted EPS of $1.90, ahead of the consensus of $1.87 and higher than $0.05 posted a year ago. It reported a profit of...
Via
Benzinga
A Look Into Zimmer Biomet's Price Over Earnings
July 30, 2021
Looking into the current session, Zimmer Biomet Holdings Inc. (NYSE:ZBH) is trading at $162.42, after a 0.20% drop. Over the past month, the stock decreased by 0.68...
Via
Benzinga
This Part of the Reopening Trade Is Just Getting Started
June 05, 2021
As hospitals address the major backlog of pandemic-postponed elective surgeries, medical device makers -- and their stock prices -- could benefit.
Via
The Motley Fool
Exposures
COVID-19
Earnings Scheduled For August 3, 2021
August 03, 2021
Companies Reporting Before The Bell • Myriad Genetics (NASDAQ:MYGN) is likely to report earnings for its fourth quarter. • Stellantis (NYSE:STLA) is expected to...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 25, 2021
May 25, 2021
Upgrades For Appian Corp (NASDAQ:APPN), Macquarie upgraded the previous rating of Underperform to Neutral. For the first quarter, Appian had an EPS of $0.06, compared to...
Via
Benzinga
1 More Excellent Reason to Love This Leading Healthcare Company
May 15, 2021
As elective surgery candidates return to operating rooms, revenue will ramp up.
Via
The Motley Fool
Exposures
COVID-19
Zimmer Biomet Holdings Inc (ZBH) Q1 2021 Earnings Call Transcript
May 04, 2021
ZBH earnings call for the period ending March 31, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Zimmer Biomet Stock Dips Despite Q1 Earnings Beat, Better-Than-Expected Guidance
May 04, 2021
Zimmer Biomet Holdings Inc (NYSE: ZBH) shares took a hit today despite first-quarter results beating the consensus. Adjusted diluted EPS of $1.71, grew 0.6% Y...
Via
Benzinga
Topics
Earnings
Exposures
Financial
The Daily Biotech Pulse: Vaxart Rebounds On Strong Vaccine Data, Pfizer's Beat-And-Raise Quarter, BioLineRx Data
May 04, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 3) AbbVie Inc. (NYSE: ABBV)...
Via
Benzinga
Earnings Scheduled For May 4, 2021
May 04, 2021
Companies Reporting Before The Bell • Lancaster Colony (NASDAQ:LANC) is likely to report quarterly earnings at $1.24 per share on revenue of $340.02 million. •...
Via
Benzinga
Zimmer Biomet Holdings Earnings Preview
May 03, 2021
Zimmer Biomet Holdings (NYSE:ZBH) announces its next round of earnings this Tuesday, May 04. Here is Benzinga's everything-that-matters guide for this Tuesday's Q1 earnings...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.